Fresenius scraps FRN, prices at tight end of guidance
Fresenius Medical Care priced its high yield bonds at the tight end of price talk on Thursday. The world’s largest provider of kidney dialysis products and services sold €684m equivalent of euro and dollar senior unsecured notes – more than the initially targeted €614.3m.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts